Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly
NCT02765126 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2017-07-27
Summary
Vaccines can have non-targeted or heterologous (also called non-specific) immunological effects on the immune system i.e. effects other than inducing an immune response against the disease targeted by the vaccine. This trial aims to evaluate the non-specific immunological effects of two vaccines - diphtheria-tetanus-acellular pertussis (DTP) vaccine and seasonal influenza vaccine - in a cohort of elderly humans (\>65 years of age) and healthy adult control subjects (30-50 years).
Conditions
- Heterologous Effects of Vaccines
Interventions
- BIOLOGICAL
-
Seasonal influenza vaccine
Intramuscular standard seasonal influenza vaccine
- BIOLOGICAL
-
Diphtheria-tetanus-acellular pertussis vaccine
Intramuscular DTaP vaccine
Sponsors & Collaborators
- collaborator OTHER
-
The Peter Doherty Institute for Infection and Immunity
collaborator OTHER -
University of Sao Paulo
collaborator OTHER -
Johns Hopkins Bloomberg School of Public Health
collaborator OTHER -
Clifford Craig Medical Research Trust
lead OTHER
Principal Investigators
-
Katie Flanagan, PhD FRACP · Clifford Craig Medical Research Trust
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- Australia
Study Locations
More Related Trials
-
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects
NCT01356316 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
NCT01967368 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine
NCT05471531 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
NCT04363359 ·Status: COMPLETED ·Phase: PHASE2
-
Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines
NCT06676644 ·Status: RECRUITING ·Phase: NA
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older
NCT02710409 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
NCT02553343 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older
NCT00975572 ·Status: COMPLETED ·Phase: PHASE2
-
Systems Biology of Trivalent Influenza Vaccine (TIV) in Young and Elderly
NCT01232868 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
NCT07302256 ·Status: RECRUITING ·Phase: PHASE1
-
Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults
NCT01701752 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population
NCT02236052 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Aging on Primary and Secondary Vaccine Responses
NCT03312699 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects
NCT01752881 ·Status: COMPLETED ·Phase: PHASE4
-
Recombinant H7 Hemagglutinin Influenza Vaccine Trial
NCT03038776 ·Status: COMPLETED ·Phase: PHASE1
-
Two-site Intradermal Influenza Vaccination in Elderly
NCT01202552 ·Status: COMPLETED ·Phase: NA
-
Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years
NCT02247362 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Trial With Influenza A/H1N1 Vaccines
NCT00956111 ·Status: COMPLETED ·Phase: PHASE4
-
Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older
NCT04622592 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season
NCT01457027 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
NCT04806529 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older
NCT05071313 ·Status: COMPLETED ·Phase: PHASE3
-
Elderly Influenza Vaccine Immunogenicity Substudy
NCT00170482 ·Status: COMPLETED
-
Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly
NCT00391053 ·Status: COMPLETED ·Phase: PHASE3